Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidence

• Tipo: Outra Publicação em Revista Científica Internacional
• Data: 2022

Autores

Tavares, V (Autor) Outra; Neto, BV (Autor) Outra; Vilas-Boas, MI (Autor) Outra; Pereira, D (Autor) Outra; Rui Medeiros (Autor) ICBAS

Revista

Título: Biochimica et Biophysica Acta - Reviews on Cancer

Vol. 1877

ISSN: 0304-419X

Editora: Elsevier

Indexação

ISI Web of Knowledge - 10 Citações

Scopus - 12 Citações

Outras Informações

ID Authenticus: P-00X-402

DOI: 10.1016/j.bbcan.2022.188778

Abstract (EN): Venous thromboembolism (VTE) is a cardiovascular disorder frequently diagnosed among cancer patients. Aside from being common, VTE severely deteriorates the prognosis of these patients as they face a higher risk of morbidity and mortality, which makes clinical tools able to identify the patients more prompt to thrombogenesis very attractive. Over the years, several genetic polymorphisms have been linked with VTE susceptibility in the general population. However, their clinical usefulness as predictive biomarkers for cancer-related VTE is yet unclear. Furthermore, as a two-way association between cancer and VTE is well-recognized, with haemostatic components fuelling tumour progression, haemostatic gene polymorphisms constitute potential cancer predictive and/or prognostic biomarkers as well. Thus, in this article, we review the existing evidence on the role of these polymorphisms on cancer-related VTE and their impact on cancer onset and progression. Despite the promising findings, the existing studies had inconsistent results most likely due to their limited statistical power and population heterogeneity. Future studies are therefore required to clarify the role of these polymorphisms in setting of malignancy.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 11